Isracann Biosciences Inc. (ISCNF) 은(는) 상장 기업입니다 헬스케어 섹터의 Drug Manufacturers - Specialty & Generic 산업에서 운영. 본사 소재지는 Vancouver, BC, 캐나다. 현재 CEO는 Ajay Singh Kaila.
ISCNF 을(를) 보유 IPO 날짜 2017-12-15, 에 상장 Other OTC, 시가총액 $1.98K.
Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. The company also develops cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.